Stem cells are being studied for meniscus repair, but an injection cannot currently be expected to reliably reconnect or fully regenerate every torn meniscus.

The answer depends on the type of tear, where it is located, whether it is traumatic or degenerative, how much blood supply reaches the damaged area, and whether osteoarthritis is also present.

There is growing research into mesenchymal stem cells, or MSCs, as a biological support for meniscal healing. Some of the newest clinical research has investigated MSCs together with surgical meniscus repair. This is different from receiving an intra-articular UC-MSC injection alone.

For patients considering regenerative treatment, the realistic question is therefore not simply, “Can stem cells regrow my meniscus?” It is whether biological treatment may help the symptoms and joint environment associated with a particular meniscal injury.

What Does the Meniscus Actually Do?

The meniscus are two crescent-shaped structures located between the thigh bone and shin bone inside the knee.

They help distribute load across the joint, absorb shock, improve stability, and protect the articular cartilage covering the ends of the bones.

This is why preserving meniscal tissue is important when possible. Removing part of the meniscus changes the way forces pass through the knee and may contribute to greater stress on the remaining joint surfaces over time.

Modern orthopedic treatment therefore places increasing emphasis on preserving and repairing the meniscus when the tear is suitable for repair. The 2024 American Academy of Orthopaedic Surgeons guideline similarly recommends preserving as much functional meniscal tissue as possible when surgery is indicated.

Why Do Some Meniscus Tears Heal Better Than Others?

Blood supply is one of the most important factors affecting meniscal healing.

The outer portion of the meniscus has substantially more blood supply than the inner portion. Clinicians commonly describe these areas as the red-red, red-white, and white-white zones.

The red-red zone is located toward the outer edge and has the greatest vascular supply. The red-white zone has an intermediate blood supply. The inner white-white zone is largely avascular, which means it receives very little direct blood supply.

This matters because blood brings cells, oxygen, nutrients, and biological factors involved in tissue repair.

A tear in the well vascularized outer region generally has greater natural healing potential than a tear deep within the inner portion of the meniscus. Research examining meniscus repair has consistently found better healing in more vascular areas. However, location is only one factor. Tear pattern, size, stability, age of the injury, knee alignment, cartilage condition, and associated injuries also influence treatment decisions.

Is a Traumatic Meniscus Tear Different From a Degenerative Tear?

Yes. This distinction is important when discussing stem cell therapy. A traumatic meniscal tear often occurs after a twisting or sports injury. These tears may appear in younger patients and can include vertical, longitudinal, radial, flap, or bucket-handle patterns.

Some traumatic tears are mechanically unstable. A piece of meniscus may move out of its normal position and interfere with knee movement.

Degenerative meniscal tears develop differently. Rather than resulting from one major injury, the meniscal tissue gradually becomes weaker and develops changes over time. These tears are particularly common in middle-aged and older adults and may occur alongside cartilage degeneration and osteoarthritis.

In this situation, treating the MRI finding alone may not address the entire source of pain.

Large randomized studies have shown that exercise-based rehabilitation can produce outcomes comparable with arthroscopic partial meniscectomy for many patients with degenerative meniscal tears. At five years, physical therapy remained noninferior to surgery for patient-reported knee function in one major randomized trial.

This is why a degenerative meniscal tear should be assessed as part of the entire knee rather than viewed as an isolated piece of damaged tissue.

Can UC-MSCs Heal a Meniscus Tear?

Current evidence does not support telling patients that an intra-articular UC-MSC injection will reliably close, reconnect, or completely regenerate a torn meniscus.

MSCs are studied because of their ability to influence inflammation, cell signaling, and tissue repair processes. These biological effects may potentially improve the environment within an injured or degenerative knee.

Clinical research into MSCs for meniscal injuries has reported improvements in symptoms and, in some studies, changes seen on imaging. However, systematic reviews have also emphasized that the available studies differ considerably in cell source, treatment method, patient selection, and outcome assessment. There is still insufficient evidence to establish a standard stem cell treatment that consistently regenerates normal human meniscal tissue. For this reason, symptom improvement and structural meniscus healing should not be treated as the same outcome. A patient may experience less pain even if an MRI continues to show the tear.

What Does the New Research on Stem Cells and Meniscus Repair Show?

An important development is that researchers are studying MSCs as an addition to surgical meniscus repair.

A 2026 multicenter clinical study evaluated patients whose torn menisci were first repaired with sutures. Cultured synovial MSCs were then transplanted directly to the injury site several weeks later. The study reported improvements in knee function as well as encouraging arthroscopic and MRI findings over follow-up. This is promising research, but it needs to be interpreted correctly.

The treatment involved meniscal suturing followed by locally transplanted synovial MSCs. It was not a standard intra-articular injection of donor UC-MSCs.

The cells also came from synovial tissue and were used specifically as an augmentation to a structural repair.

This means the study should not be used to claim that a routine UC-MSC injection can repair every meniscus tear without surgery.

Instead, it shows where the field may be moving: combining mechanical repair with biological support to improve healing in tears that are difficult to treat.

Can Stem Cells Help a Degenerative Meniscus Tear?

Potentially, but the treatment goal may be different from physically repairing the tear.

A patient with a degenerative meniscus tear often has other changes within the knee, including cartilage wear, inflammation, bone changes, muscle weakness, or early osteoarthritis.

In this setting, UC-MSC therapy may be considered for its potential effects on pain, inflammation, and the broader joint environment rather than with the expectation that it will stitch the torn meniscus back together.

This distinction is especially important for older patients whose MRI shows both a meniscal tear and osteoarthritis.

The tear may be one part of the problem rather than the only source of symptoms.

Treatment should therefore be based on the patient’s pain, function, examination, imaging, and overall degree of joint degeneration.

What About a Mechanical or Displaced Meniscus Tear?

Stem cell therapy cannot mechanically reposition a displaced piece of meniscus.

A bucket-handle tear, for example, can cause a substantial portion of the meniscus to move into the joint and physically block normal knee movement. This is a structural problem.

The AAOS guideline states that patients with an acute displaced or displacing meniscal tear, particularly when it restricts knee range of motion, may benefit from early surgical intervention. When repair is possible, preserving the meniscus is generally preferred over removing unnecessary tissue.

This is different from occasional clicking or catching. Mechanical symptoms alone do not automatically mean surgery is required, particularly in degenerative meniscal disease. Randomized research has not shown that patients with ordinary mechanical symptoms from degenerative tears necessarily benefit more from partial meniscectomy. A truly locked knee caused by a displaced tear is a different clinical situation and warrants orthopedic assessment.

Can Stem Cells Help if Meniscus Damage Occurs With Osteoarthritis?

This is one of the more relevant situations for regenerative medicine. Meniscal degeneration and knee osteoarthritis frequently occur together. As the meniscus loses its ability to distribute load normally, cartilage may experience greater mechanical stress. At the same time, osteoarthritis can cause further deterioration of the meniscus.

UC-MSC treatment in this setting is better understood as treatment directed toward the overall osteoarthritic joint environment rather than isolated meniscal reconstruction.

Clinical research into MSCs for knee osteoarthritis has reported improvements in pain and physical function in some patients, although responses vary and structural regeneration remains uncertain.

The amount of remaining cartilage, alignment, degree of arthritis, meniscal condition, body weight, muscle strength, and activity demands should all be considered when evaluating whether regenerative treatment is reasonable.

When Is Surgery More Appropriate Than Stem Cell Therapy?

Surgery becomes more relevant when the main problem is mechanical rather than biological. A displaced tear blocking knee movement cannot be corrected by reducing inflammation. A large unstable tear may require repair, and some tears may need partial removal when preservation is not technically possible.

The goal should not automatically be surgery or automatically be stem cell treatment. The correct approach depends on what is actually causing the patient’s symptoms.

For a degenerative tear without major mechanical obstruction, rehabilitation and conservative treatment may be appropriate first. For a repairable traumatic tear, preserving the meniscus through surgical repair may provide the best structural solution. For a degenerative knee with osteoarthritis, regenerative treatment may sometimes be considered as part of a broader treatment strategy.

What Should Patients Expect From Stem Cell Treatment for a Meniscus Tear?

Expectations should focus on what biological treatment may realistically support. UC-MSC therapy may potentially help reduce pain and influence the inflammatory environment inside the knee. Some patients may experience better function as symptoms improve.

What patients should not be promised is guaranteed closure of the meniscal tear or restoration of a completely normal meniscus on MRI.

Current research into meniscal regeneration is advancing, including recent studies combining MSCs with surgical repair. But these specialized techniques remain different from routine UC-MSC joint injections.

For this reason, MRI findings should be reviewed together with symptoms and a physical examination before deciding whether regenerative treatment, rehabilitation, surgical repair, or another approach is most appropriate.

Frequently Asked Questions

• Can stem cells completely heal a torn meniscus?

There is not enough evidence to say that a standard stem cell injection can reliably close or completely regenerate a torn meniscus. MSCs may support the biological environment of the knee, while specialized research is investigating MSCs as an addition to surgical meniscus repair.

• Can stem cells help a degenerative meniscus tear?

They may be considered when the tear occurs as part of broader knee degeneration or osteoarthritis. In this situation, the goal is generally symptom improvement and biological support rather than physically reconnecting the torn meniscus.

• Which meniscus tears heal best?

Tears closer to the outer vascular region of the meniscus generally have better healing potential. Tears in the inner white-white zone have much less blood supply and are more difficult to heal naturally.

• Can stem cells fix a bucket-handle meniscus tear?

Stem cells cannot mechanically reposition a displaced meniscal fragment. A bucket-handle tear that restricts knee movement should be assessed by an orthopedic surgeon to determine whether repair is appropriate.

• Can stem cells help after part of the meniscus has already been removed?

Stem cell therapy cannot recreate a surgically removed section of meniscus. It may be considered in selected patients when persistent symptoms are related to inflammation or degenerative changes in the remaining joint, but expectations should remain realistic.

Medically reviewed by Dr. Naputt Virasathienpornkul, M.D.
Orthopedic Surgeon, Sports Medicine & Joint Conditions

Related Reading

• Stem Cell Therapy: Benefits, Limitations, and Realistic Expectations
• Why Rehabilitation Matters After Stem Cell Therapy
• Can You Exercise After a Stem Cell Injection?

About EDNA Wellness

EDNA Wellness is a surgeon-led regenerative medicine center in Bangkok, specializing in orthopedic and neurological conditions using Umbilical Cord Derived Mesenchymal Stem Cells (UC-MSCs).

All cases are reviewed by orthopedic surgeons and neurosurgeons, with a focus on clinical indication, patient safety, and realistic treatment expectations. Stem cell therapy is recommended selectively, and alternative treatments are considered when more appropriate.

For more information or to book a consultation:

LINE: @ednawellness
WhatsApp: +66 (0) 64 505 5599
Website: www.ednawellness.com

References

• Sekiya I, Ozeki N, Koga H, et al. Synovial mesenchymal stem cell-augmented meniscal repair for flap tears: A phase III multicenter clinical trial. Journal of Orthopaedic Science. 2026. https://pubmed.ncbi.nlm.nih.gov/42270542/
• Longo UG, Campi S, Romeo G, et al. Stem cells application in meniscal tears: a systematic review of pre-clinical and clinical evidence. 2022. https://pubmed.ncbi.nlm.nih.gov/34982437/
• Whitehouse MR, Howells NR, Parry MC, et al. Mesenchymal stem cells in human meniscal regeneration: A systematic review. Annals of Medicine and Surgery. 2017. https://pubmed.ncbi.nlm.nih.gov/29062478/
• Yan R, Dai W, Cheng J, et al. Advances in the Mechanisms Affecting Meniscal Avascular Zone Repair and Therapies. Frontiers in Cell and Developmental Biology. 2021. https://pubmed.ncbi.nlm.nih.gov/34778268/
• Noorduyn JCA, Glastra van Loon T, van de Graaf VA, et al. Effect of Physical Therapy vs Arthroscopic Partial Meniscectomy in People With Degenerative Meniscal Tears: Five-Year Follow-up of the ESCAPE Randomized Clinical Trial. JAMA Network Open. 2022. https://pubmed.ncbi.nlm.nih.gov/35802374/